Bov.Virus*3/M Haem/Past Mult

Verify with FDA CVM →

49 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
49
Total Reports
43
Deaths Reported
8780.0%
Death Rate

Active Ingredients

Bov.Virus*3/M Haem/Past Mult

Administration Routes

NasalUnknownSubcutaneous

Species Affected

Cattle 49

Most Affected Breeds

Cattle (other) 30
Crossbred Bovine/Cattle 8
Holstein-Friesian also known as Holstein 3
Brangus 2
Aberdeen Angus 2
Cattle (unspecified) 1
Simmental 1
Hereford cattle 1
Highland 1

Most Reported Reactions

Death 40
Lack of efficacy - NOS 27
Lack of efficacy (bacteria) - NOS 11
Necropsy performed 6
Death by euthanasia 3
Found dead 3
Lack of efficacy (virus) - coronavirus - NOS 2
Lack of efficacy (virus) - coronavirus (Infectious Bronchitis Virus) 2
Distress 1
Pain NOS 1
Respiratory distress 1
Neck writhing 1

Outcome Breakdown

Died
43 (42.2%)
Ongoing
21 (20.6%)
Recovered/Normal
20 (19.6%)
Outcome Unknown
14 (13.7%)
Euthanized
4 (3.9%)

Data Summary

Metric Value
Total adverse event reports 49
Reports involving death 43
Case-fatality rate (reported events) 8780.0%
Distinct species in reports 1
Distinct breeds in reports 9
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Bov.Virus*3/M Haem/Past Mult Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 49 adverse event reports referencing Bov.Virus*3/M Haem/Past Mult, including 43 reports in which the animal died — a 8780.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Bov.Virus*3/M Haem/Past Mult. Reported administration routes include Nasal, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Bov.Virus*3/M Haem/Past Mult reports are Cattle (49 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (30), Crossbred Bovine/Cattle (8), Holstein-Friesian also known as Holstein (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Bov.Virus*3/M Haem/Past Mult are Death (40), Lack of efficacy - NOS (27), Lack of efficacy (bacteria) - NOS (11), Necropsy performed (6). Of the 102 reports with a coded outcome, Died is the leading category at 42.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Bov.Virus*3/M Haem/Past Mult.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial